scispace - formally typeset
Search or ask a question

Showing papers by "University of Colorado Boulder published in 2018"


Journal ArticleDOI
Jeffrey D. Stanaway1, Ashkan Afshin1, Emmanuela Gakidou1, Stephen S Lim1  +1050 moreInstitutions (346)
TL;DR: This study estimated levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017 and explored the relationship between development and risk exposure.

2,910 citations


Journal ArticleDOI
TL;DR: Larotrectinib had marked and durable antitumor activity in patients with TRK fusion–positive cancer, regardless of the age of the patient or of the tumor type.
Abstract: Background Fusions involving one of three tropomyosin receptor kinases (TRK) occur in diverse cancers in children and adults. We evaluated the efficacy and safety of larotrectinib, a highly selective TRK inhibitor, in adults and children who had tumors with these fusions. Methods We enrolled patients with consecutively and prospectively identified TRK fusion–positive cancers, detected by molecular profiling as routinely performed at each site, into one of three protocols: a phase 1 study involving adults, a phase 1–2 study involving children, or a phase 2 study involving adolescents and adults. The primary end point for the combined analysis was the overall response rate according to independent review. Secondary end points included duration of response, progression-free survival, and safety. Results A total of 55 patients, ranging in age from 4 months to 76 years, were enrolled and treated. Patients had 17 unique TRK fusion–positive tumor types. The overall response rate was 75% (95% confidence ...

1,773 citations


Journal ArticleDOI
TL;DR: Recommendations regarding the use of the EEO concept, including the upscaling of laboratory results, were derived from an extensive analysis of studies reported in the peer-reviewed literature enabling a critical comparison of various established and emerging AOPs based on electrical energy per order (EEO) values.

1,677 citations


Journal ArticleDOI
James J. Lee1, Robbee Wedow2, Aysu Okbay3, Edward Kong4, Omeed Maghzian4, Meghan Zacher4, Tuan Anh Nguyen-Viet5, Peter Bowers4, Julia Sidorenko6, Julia Sidorenko7, Richard Karlsson Linnér8, Richard Karlsson Linnér3, Mark Alan Fontana5, Mark Alan Fontana9, Tushar Kundu5, Chanwook Lee4, Hui Li4, Ruoxi Li5, Rebecca Royer5, Pascal Timshel10, Pascal Timshel11, Raymond K. Walters4, Raymond K. Walters12, Emily A. Willoughby1, Loic Yengo7, Maris Alver6, Yanchun Bao13, David W. Clark14, Felix R. Day15, Nicholas A. Furlotte, Peter K. Joshi14, Peter K. Joshi16, Kathryn E. Kemper7, Aaron Kleinman, Claudia Langenberg15, Reedik Mägi6, Joey W. Trampush5, Shefali S. Verma17, Yang Wu7, Max Lam, Jing Hua Zhao15, Zhili Zheng18, Zhili Zheng7, Jason D. Boardman2, Harry Campbell14, Jeremy Freese19, Kathleen Mullan Harris20, Caroline Hayward14, Pamela Herd21, Pamela Herd13, Meena Kumari13, Todd Lencz22, Todd Lencz23, Jian'an Luan15, Anil K. Malhotra23, Anil K. Malhotra22, Andres Metspalu6, Lili Milani6, Ken K. Ong15, John R. B. Perry15, David J. Porteous14, Marylyn D. Ritchie17, Melissa C. Smart14, Blair H. Smith24, Joyce Y. Tung, Nicholas J. Wareham15, James F. Wilson14, Jonathan P. Beauchamp25, Dalton Conley26, Tõnu Esko6, Steven F. Lehrer27, Steven F. Lehrer28, Steven F. Lehrer29, Patrik K. E. Magnusson30, Sven Oskarsson31, Tune H. Pers10, Tune H. Pers11, Matthew R. Robinson32, Matthew R. Robinson7, Kevin Thom33, Chelsea Watson5, Christopher F. Chabris17, Michelle N. Meyer17, David Laibson4, Jian Yang7, Magnus Johannesson34, Philipp Koellinger3, Philipp Koellinger8, Patrick Turley4, Patrick Turley12, Peter M. Visscher7, Daniel J. Benjamin5, Daniel J. Benjamin27, David Cesarini27, David Cesarini33 
TL;DR: A joint (multi-phenotype) analysis of educational attainment and three related cognitive phenotypes generates polygenic scores that explain 11–13% of the variance ineducational attainment and 7–10% ofthe variance in cognitive performance, which substantially increases the utility ofpolygenic scores as tools in research.
Abstract: Here we conducted a large-scale genetic association analysis of educational attainment in a sample of approximately 1.1 million individuals and identify 1,271 independent genome-wide-significant SNPs. For the SNPs taken together, we found evidence of heterogeneous effects across environments. The SNPs implicate genes involved in brain-development processes and neuron-to-neuron communication. In a separate analysis of the X chromosome, we identify 10 independent genome-wide-significant SNPs and estimate a SNP heritability of around 0.3% in both men and women, consistent with partial dosage compensation. A joint (multi-phenotype) analysis of educational attainment and three related cognitive phenotypes generates polygenic scores that explain 11-13% of the variance in educational attainment and 7-10% of the variance in cognitive performance. This prediction accuracy substantially increases the utility of polygenic scores as tools in research.

1,658 citations


Journal ArticleDOI
19 Jan 2018-Science
TL;DR: This study narrows down the immense number of bacterial taxa to a “most wanted” list that will be fruitful targets for genomic and cultivation-based efforts aimed at improving the understanding of soil microbes and their contributions to ecosystem functioning.
Abstract: The immense diversity of soil bacterial communities has stymied efforts to characterize individual taxa and document their global distributions. We analyzed soils from 237 locations across six continents and found that only 2% of bacterial phylotypes (~500 phylotypes) consistently accounted for almost half of the soil bacterial communities worldwide. Despite the overwhelming diversity of bacterial communities, relatively few bacterial taxa are abundant in soils globally. We clustered these dominant taxa into ecological groups to build the first global atlas of soil bacterial taxa. Our study narrows down the immense number of bacterial taxa to a “most wanted” list that will be fruitful targets for genomic and cultivation-based efforts aimed at improving our understanding of soil microbes and their contributions to ecosystem functioning.

1,204 citations


Journal ArticleDOI
TL;DR: A hierarchically nanostructured gel (HNG) based on polyvinyl alcohol (PVA) and polypyrrole (PPy) that serves as an independent solar vapour generator that enables highly efficient solar vapours generation.
Abstract: Solar vapour generation is an efficient way of harvesting solar energy for the purification of polluted or saline water. However, water evaporation suffers from either inefficient utilization of solar energy or relies on complex and expensive light-concentration accessories. Here, we demonstrate a hierarchically nanostructured gel (HNG) based on polyvinyl alcohol (PVA) and polypyrrole (PPy) that serves as an independent solar vapour generator. The converted energy can be utilized in situ to power the vaporization of water contained in the molecular meshes of the PVA network, where water evaporation is facilitated by the skeleton of the hydrogel. A floating HNG sample evaporated water with a record high rate of 3.2 kg m−2 h−1 via 94% solar energy from 1 sun irradiation, and 18–23 litres of water per square metre of HNG was delivered daily when purifying brine water. These values were achievable due to the reduced latent heat of water evaporation in the molecular mesh under natural sunlight. Effective energy confinement via tailored water transport in hierarchical nanostructured gels enables highly efficient solar vapour generation.

1,174 citations


Journal ArticleDOI
21 Sep 2018-Science
TL;DR: Recent progress in addressing stability, how to allow mass production, and how to maintain uniformity of large-area films are reviewed, and the remaining challenges along the pathway to their commercialization are discussed.
Abstract: BACKGROUND Perovskite solar cells (PSCs) have attracted intensive attention because of their ever-increasing power conversion effi­ciency (PCE), low-cost materials constituents, and simple solution fabrication process. Initi­ated in 2009 with an efficiency of 3.8%, PSCs have now achieved a lab-scale power conversion efficiency of 23.3%, rivaling the performance of commercial multicrystalline silicon solar cells, as well as copper indium gallium selenide (CIGS) and cadmium telluride (CdTe) thin-film solar cells. Thousands of articles re­lated to PSCs have been published each year since 2015, highlighting PSCs as a topic of in­tense interest in photovoltaics (PV) research. With high efficiencies achieved in lab devices, stability and remaining challenges in upscal­ing the manufacture of PSCs are two critical concerns that must be addressed on the path to PSC commercialization. ADVANCES We review recent progress in PSCs and discuss the remaining challenges along the pathway to their commercialization. Device configurations of PSCs (see the figure) include mesoscopic formal (n-i-p) and inverted (p-i-n) structures, planar formal and inverted struc­tures, and the printable triple mesoscopic structures. PCEs of devices that use these structures have advanced rapidly in the case of small-area devices (~0.1 cm 2 ). PSCs are also attracting attention as top cells for the construction of tandem solar cells with existing mature PV technologies to increase efficiency beyond the Shockley-Queisser limit of single-junction devices. The stability of PSCs has attracted much well-deserved attention of late, and notable progress has been made in the past few years. PSCs have recently achieved exhibited life­times of 10,000 hours under 1 sun (1 kW/m 2 ) illumina­tion with an ultraviolet filter at a stabilized temperature of 55°C and at short-circuit conditions for a printable triple mesoscopic PSCs. This irradiation is equivalent to the total irradiation of 10 years of outdoor use in most of Europe. However, within the PSC community, standard testing protocols require further development. In addition, transpar­ency in reporting standards on stability tests needs to be improved; this can be achieved by providing both initial photovoltaic performance and normalization parameters. The upscaling of PSCs has also progressed steadily, leading to PSC mini-modules, standard-sized modules, and power systems. PV companies have set out to manufacture large-area PSC modules (see the figure), and a 110-m 2 perovskite PV system with screen-printed triple mesoscopic PSC modules was recently debuted. Studies of these increased-area modules and systems will promote the development of PSCs toward commercializa­tion. PSC research is expanding to cover fundamental topics on materials and lab-sized cells, as well as to address issues of in­dustrial-scale manufacturing and deployment. OUTLOOK The PV market has been continu­ously expanding in recent years, bringing op­portunities for new PV technologies of which PSCs are promising candidates. It is impera­tive to achieve a low cost per watt, which means that both efficiency and lifetime need improve­ment relative to current parameters. The efficiency gap between lab cells and industrial modules has seen impressive reduc­tions in crystalline silicon; PSCs must simi­larly enlarge module areas to the panel level and need to achieve lifetimes comparable to those of legacy PV technologies. Other improvements will need to include industry-scale electronic-grade films, recycling methods to address concerns regarding lead toxicity, and the adoption of standardized testing protocols to predict the operation lifetime of PSCs. Modules will need to endure light-induced degradation, potential-induced degradation, partial-shade stress, and mechanical shock. The field can benefit from lessons learned during the development of mature PV technologies as it strives to de­fine, and overcome, the hurdles to PSC com­mercial impact.

1,160 citations


Journal ArticleDOI
TL;DR: An overview of the imaging procedures of the ABCD study is provided, the basis for their selection and preliminary quality assurance and results that provide evidence for the feasibility and age-appropriateness of procedures and generalizability of findings to the existent literature are provided.

1,114 citations


Journal ArticleDOI
TL;DR: The capabilities and design philosophy of the current version of the PySCF package are document, which is as efficient as the best existing C or Fortran‐based quantum chemistry programs.
Abstract: Python-based simulations of chemistry framework (PySCF) is a general-purpose electronic structure platform designed from the ground up to emphasize code simplicity, so as to facilitate new method development and enable flexible computational workflows. The package provides a wide range of tools to support simulations of finite-size systems, extended systems with periodic boundary conditions, low-dimensional periodic systems, and custom Hamiltonians, using mean-field and post-mean-field methods with standard Gaussian basis functions. To ensure ease of extensibility, PySCF uses the Python language to implement almost all of its features, while computationally critical paths are implemented with heavily optimized C routines. Using this combined Python/C implementation, the package is as efficient as the best existing C or Fortran-based quantum chemistry programs. In this paper, we document the capabilities and design philosophy of the current version of the PySCF package. WIREs Comput Mol Sci 2018, 8:e1340. doi: 10.1002/wcms.1340 This article is categorized under: Structure and Mechanism > Computational Materials Science Electronic Structure Theory > Ab Initio Electronic Structure Methods Software > Quantum Chemistry

1,042 citations


Journal ArticleDOI
13 Dec 2018-Cell
TL;DR: It is reported that diverse ADs form phase- separated condensates with the Mediator coactivator, suggesting that diverse TFs can interact with Mediator through the phase-separating capacity of their ADs and that formation of condensate with Mediation is involved in gene activation.

1,040 citations


Journal ArticleDOI
24 Oct 2018-Nature
TL;DR: Analysis of stool samples from 903 children as part of the TEDDY study shows that breastfeeding was the most important factor associated with microbiome structure, and the cessation of breast milk resulted in faster maturation of the gut microbiome.
Abstract: The development of the microbiome from infancy to childhood is dependent on a range of factors, with microbial–immune crosstalk during this time thought to be involved in the pathobiology of later life diseases1–9 such as persistent islet autoimmunity and type 1 diabetes10–12. However, to our knowledge, no studies have performed extensive characterization of the microbiome in early life in a large, multi-centre population. Here we analyse longitudinal stool samples from 903 children between 3 and 46 months of age by 16S rRNA gene sequencing (n = 12,005) and metagenomic sequencing (n = 10,867), as part of the The Environmental Determinants of Diabetes in the Young (TEDDY) study. We show that the developing gut microbiome undergoes three distinct phases of microbiome progression: a developmental phase (months 3–14), a transitional phase (months 15–30), and a stable phase (months 31–46). Receipt of breast milk, either exclusive or partial, was the most significant factor associated with the microbiome structure. Breastfeeding was associated with higher levels of Bifidobacterium species (B. breve and B. bifidum), and the cessation of breast milk resulted in faster maturation of the gut microbiome, as marked by the phylum Firmicutes. Birth mode was also significantly associated with the microbiome during the developmental phase, driven by higher levels of Bacteroides species (particularly B. fragilis) in infants delivered vaginally. Bacteroides was also associated with increased gut diversity and faster maturation, regardless of the birth mode. Environmental factors including geographical location and household exposures (such as siblings and furry pets) also represented important covariates. A nested case–control analysis revealed subtle associations between microbial taxonomy and the development of islet autoimmunity or type 1 diabetes. These data determine the structural and functional assembly of the microbiome in early life and provide a foundation for targeted mechanistic investigation into the consequences of microbial–immune crosstalk for long-term health.

Journal ArticleDOI
28 Feb 2018-Nature
TL;DR: The detection of a flattened absorption profile in the sky-averaged radio spectrum that is largely consistent with expectations for the 21-centimetre signal induced by early stars; however, the best-fitting amplitude of the profile is more than a factor of two greater than the largest predictions.
Abstract: The 21-cm absorption profile is detected in the sky-averaged radio spectrum, but is much stronger than predicted, suggesting that the primordial gas might have been cooler than predicted. As the first stars heated hydrogen in the early Universe, the 21-cm hyperfine line—an astronomical standard that represents the spin-flip transition in the ground state of atomic hydrogen—was altered, causing the hydrogen gas to absorb photons from the microwave background. This should produce an observable absorption signal at frequencies of less than 200 megahertz (MHz). Judd Bowman and colleagues report the observation of an absorption profile centred at a frequency of 78 MHz that is about 19 MHz wide and 0.5 kelvin deep. The profile is generally in line with expectations, although it is deeper than predicted. An accompanying paper by Rennan Barkana suggests that baryons were interacting with cold dark-matter particles in the early Universe, cooling the gas more than had been expected. After stars formed in the early Universe, their ultraviolet light is expected, eventually, to have penetrated the primordial hydrogen gas and altered the excitation state of its 21-centimetre hyperfine line. This alteration would cause the gas to absorb photons from the cosmic microwave background, producing a spectral distortion that should be observable today at radio frequencies of less than 200 megahertz1. Here we report the detection of a flattened absorption profile in the sky-averaged radio spectrum, which is centred at a frequency of 78 megahertz and has a best-fitting full-width at half-maximum of 19 megahertz and an amplitude of 0.5 kelvin. The profile is largely consistent with expectations for the 21-centimetre signal induced by early stars; however, the best-fitting amplitude of the profile is more than a factor of two greater than the largest predictions2. This discrepancy suggests that either the primordial gas was much colder than expected or the background radiation temperature was hotter than expected. Astrophysical phenomena (such as radiation from stars and stellar remnants) are unlikely to account for this discrepancy; of the proposed extensions to the standard model of cosmology and particle physics, only cooling of the gas as a result of interactions between dark matter and baryons seems to explain the observed amplitude3. The low-frequency edge of the observed profile indicates that stars existed and had produced a background of Lyman-α photons by 180 million years after the Big Bang. The high-frequency edge indicates that the gas was heated to above the radiation temperature less than 100 million years later.

Journal ArticleDOI
Bela Abolfathi1, D. S. Aguado2, Gabriela Aguilar3, Carlos Allende Prieto2  +361 moreInstitutions (94)
TL;DR: SDSS-IV is the fourth generation of the Sloan Digital Sky Survey and has been in operation since 2014 July. as discussed by the authors describes the second data release from this phase, and the 14th from SDSS overall (making this Data Release Fourteen or DR14).
Abstract: The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) has been in operation since 2014 July. This paper describes the second data release from this phase, and the 14th from SDSS overall (making this Data Release Fourteen or DR14). This release makes the data taken by SDSS-IV in its first two years of operation (2014-2016 July) public. Like all previous SDSS releases, DR14 is cumulative, including the most recent reductions and calibrations of all data taken by SDSS since the first phase began operations in 2000. New in DR14 is the first public release of data from the extended Baryon Oscillation Spectroscopic Survey; the first data from the second phase of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE-2), including stellar parameter estimates from an innovative data-driven machine-learning algorithm known as "The Cannon"; and almost twice as many data cubes from the Mapping Nearby Galaxies at APO (MaNGA) survey as were in the previous release (N = 2812 in total). This paper describes the location and format of the publicly available data from the SDSS-IV surveys. We provide references to the important technical papers describing how these data have been taken (both targeting and observation details) and processed for scientific use. The SDSS web site (www.sdss.org) has been updated for this release and provides links to data downloads, as well as tutorials and examples of data use. SDSS-IV is planning to continue to collect astronomical data until 2020 and will be followed by SDSS-V.

Journal ArticleDOI
Ali H. Mokdad1, Katherine Ballestros1, Michelle Echko1, Scott D Glenn1, Helen E Olsen1, Erin C Mullany1, Alexander Lee1, Abdur Rahman Khan2, Alireza Ahmadi3, Alireza Ahmadi4, Alize J. Ferrari1, Alize J. Ferrari5, Alize J. Ferrari6, Amir Kasaeian7, Andrea Werdecker, Austin Carter1, Ben Zipkin1, Benn Sartorius8, Benn Sartorius9, Berrin Serdar10, Bryan L. Sykes11, Christopher Troeger1, Christina Fitzmaurice1, Christina Fitzmaurice12, Colin D. Rehm13, Damian Santomauro1, Damian Santomauro5, Damian Santomauro6, Daniel Kim14, Danny V. Colombara1, David C. Schwebel15, Derrick Tsoi1, Dhaval Kolte16, Elaine O. Nsoesie1, Emma Nichols1, Eyal Oren17, Fiona J Charlson1, Fiona J Charlson5, Fiona J Charlson6, George C Patton18, Gregory A. Roth1, H. Dean Hosgood19, Harvey Whiteford5, Harvey Whiteford6, Harvey Whiteford1, Hmwe H Kyu1, Holly E. Erskine6, Holly E. Erskine5, Holly E. Erskine1, Hsiang Huang20, Ira Martopullo1, Jasvinder A. Singh15, Jean B. Nachega21, Jean B. Nachega22, Jean B. Nachega23, Juan Sanabria24, Juan Sanabria25, Kaja Abbas26, Kanyin Ong1, Karen M. Tabb27, Kristopher J. Krohn1, Leslie Cornaby1, Louisa Degenhardt28, Louisa Degenhardt1, Mark Moses1, Maryam S. Farvid29, Max Griswold1, Michael H. Criqui30, Michelle L. Bell31, Minh Nguyen1, Mitch T Wallin32, Mitch T Wallin33, Mojde Mirarefin1, Mostafa Qorbani, Mustafa Z. Younis34, Nancy Fullman1, Patrick Liu1, Paul S Briant1, Philimon Gona35, Rasmus Havmoller3, Ricky Leung36, Ruth W Kimokoti37, Shahrzad Bazargan-Hejazi38, Shahrzad Bazargan-Hejazi39, Simon I. Hay1, Simon I. Hay40, Simon Yadgir1, Stan Biryukov1, Stein Emil Vollset41, Stein Emil Vollset1, Tahiya Alam1, Tahvi Frank1, Talha Farid2, Ted R. Miller42, Ted R. Miller43, Theo Vos1, Till Bärnighausen44, Till Bärnighausen29, Tsegaye Telwelde Gebrehiwot45, Yuichiro Yano46, Ziyad Al-Aly47, Alem Mehari48, Alexis J. Handal49, Amit Kandel50, Ben Anderson51, Brian J. Biroscak52, Brian J. Biroscak31, Dariush Mozaffarian53, E. Ray Dorsey54, Eric L. Ding29, Eun-Kee Park55, Gregory R. Wagner29, Guoqing Hu56, Honglei Chen57, Jacob E. Sunshine51, Jagdish Khubchandani58, Janet L Leasher59, Janni Leung5, Janni Leung51, Joshua A. Salomon29, Jürgen Unützer51, Leah E. Cahill29, Leah E. Cahill60, Leslie T. Cooper61, Masako Horino, Michael Brauer62, Michael Brauer1, Nicholas J K Breitborde63, Peter J. Hotez64, Roman Topor-Madry65, Roman Topor-Madry66, Samir Soneji67, Saverio Stranges68, Spencer L. James1, Stephen M. Amrock69, Sudha Jayaraman70, Tejas V. Patel, Tomi Akinyemiju15, Vegard Skirbekk41, Vegard Skirbekk71, Yohannes Kinfu72, Zulfiqar A Bhutta73, Jost B. Jonas44, Christopher J L Murray1 
Institute for Health Metrics and Evaluation1, University of Louisville2, Karolinska Institutet3, Kermanshah University of Medical Sciences4, University of Queensland5, Centre for Mental Health6, Tehran University of Medical Sciences7, South African Medical Research Council8, University of KwaZulu-Natal9, University of Colorado Boulder10, University of California, Irvine11, Fred Hutchinson Cancer Research Center12, Montefiore Medical Center13, Northeastern University14, University of Alabama at Birmingham15, Brown University16, San Diego State University17, University of Melbourne18, Albert Einstein College of Medicine19, Cambridge Health Alliance20, Johns Hopkins University21, University of Pittsburgh22, University of Cape Town23, Marshall University24, Case Western Reserve University25, University of London26, University of Illinois at Urbana–Champaign27, National Drug and Alcohol Research Centre28, Harvard University29, University of California, San Diego30, Yale University31, Georgetown University32, Veterans Health Administration33, Jackson State University34, University of Massachusetts Boston35, State University of New York System36, Simmons College37, University of California, Los Angeles38, Charles R. Drew University of Medicine and Science39, University of Oxford40, Norwegian Institute of Public Health41, Pacific Institute42, Curtin University43, Heidelberg University44, Jimma University45, Northwestern University46, Washington University in St. Louis47, Howard University48, University of New Mexico49, University at Buffalo50, University of Washington51, University of South Florida52, Tufts University53, University of Rochester Medical Center54, Kosin University55, Central South University56, Michigan State University57, Ball State University58, Nova Southeastern University59, Dalhousie University60, Mayo Clinic61, University of British Columbia62, Ohio State University63, Baylor University64, Wrocław Medical University65, Jagiellonian University Medical College66, Dartmouth College67, University of Western Ontario68, Oregon Health & Science University69, Virginia Commonwealth University70, Columbia University71, University of Canberra72, Aga Khan University73
10 Apr 2018-JAMA
TL;DR: There are wide differences in the burden of disease at the state level and specific diseases and risk factors, such as drug use disorders, high BMI, poor diet, high fasting plasma glucose level, and alcohol use disorders are increasing and warrant increased attention.
Abstract: Introduction Several studies have measured health outcomes in the United States, but none have provided a comprehensive assessment of patterns of health by state. Objective To use the results of the Global Burden of Disease Study (GBD) to report trends in the burden of diseases, injuries, and risk factors at the state level from 1990 to 2016. Design and Setting A systematic analysis of published studies and available data sources estimates the burden of disease by age, sex, geography, and year. Main Outcomes and Measures Prevalence, incidence, mortality, life expectancy, healthy life expectancy (HALE), years of life lost (YLLs) due to premature mortality, years lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 333 causes and 84 risk factors with 95% uncertainty intervals (UIs) were computed. Results Between 1990 and 2016, overall death rates in the United States declined from 745.2 (95% UI, 740.6 to 749.8) per 100 000 persons to 578.0 (95% UI, 569.4 to 587.1) per 100 000 persons. The probability of death among adults aged 20 to 55 years declined in 31 states and Washington, DC from 1990 to 2016. In 2016, Hawaii had the highest life expectancy at birth (81.3 years) and Mississippi had the lowest (74.7 years), a 6.6-year difference. Minnesota had the highest HALE at birth (70.3 years), and West Virginia had the lowest (63.8 years), a 6.5-year difference. The leading causes of DALYs in the United States for 1990 and 2016 were ischemic heart disease and lung cancer, while the third leading cause in 1990 was low back pain, and the third leading cause in 2016 was chronic obstructive pulmonary disease. Opioid use disorders moved from the 11th leading cause of DALYs in 1990 to the 7th leading cause in 2016, representing a 74.5% (95% UI, 42.8% to 93.9%) change. In 2016, each of the following 6 risks individually accounted for more than 5% of risk-attributable DALYs: tobacco consumption, high body mass index (BMI), poor diet, alcohol and drug use, high fasting plasma glucose, and high blood pressure. Across all US states, the top risk factors in terms of attributable DALYs were due to 1 of the 3 following causes: tobacco consumption (32 states), high BMI (10 states), or alcohol and drug use (8 states). Conclusions and Relevance There are wide differences in the burden of disease at the state level. Specific diseases and risk factors, such as drug use disorders, high BMI, poor diet, high fasting plasma glucose level, and alcohol use disorders are increasing and warrant increased attention. These data can be used to inform national health priorities for research, clinical care, and policy.

Journal ArticleDOI
29 Jun 2018-Science
TL;DR: In this paper, the authors examine barriers and opportunities associated with these difficult-to-decarbonize services and processes, including possible technological solutions and research and development priorities, and examine the use of existing technologies to meet future demands for these services without net addition of CO2 to the atmosphere.
Abstract: Some energy services and industrial processes-such as long-distance freight transport, air travel, highly reliable electricity, and steel and cement manufacturing-are particularly difficult to provide without adding carbon dioxide (CO2) to the atmosphere. Rapidly growing demand for these services, combined with long lead times for technology development and long lifetimes of energy infrastructure, make decarbonization of these services both essential and urgent. We examine barriers and opportunities associated with these difficult-to-decarbonize services and processes, including possible technological solutions and research and development priorities. A range of existing technologies could meet future demands for these services and processes without net addition of CO2 to the atmosphere, but their use may depend on a combination of cost reductions via research and innovation, as well as coordinated deployment and integration of operations across currently discrete energy industries.

Journal ArticleDOI
TL;DR: The results presented in this report reflect the 4-year update of the ongoing study with a database lock date of May 10, 2018.
Abstract: Summary Background Previously reported results from the phase 3 CheckMate 067 trial showed a significant improvement in objective responses, progression-free survival, and overall survival with nivolumab plus ipilimumab or nivolumab alone compared with ipilimumab alone in patients with advanced melanoma. The aim of this report is to provide 4-year updated efficacy and safety data from this study. Methods In this phase 3 trial, eligible patients were aged 18 years or older with previously untreated, unresectable, stage III or stage IV melanoma, known BRAFV600 mutation status, and an Eastern Cooperative Oncology Group performance status of 0 or 1. Patients were randomly assigned 1:1:1 to receive intravenous nivolumab 1 mg/kg plus ipilimumab 3 mg/kg every 3 weeks for four doses, followed by nivolumab 3 mg/kg every 2 weeks, or nivolumab 3 mg/kg every 2 weeks plus placebo, or ipilimumab 3 mg/kg every 3 weeks for four doses plus placebo. Randomisation was done via an interactive voice response system with a permuted block schedule (block size of six) and stratification by PD-L1 status, BRAF mutation status, and metastasis stage. The patients, investigators, study site staff, and study funder were masked to the study drug administered. The co-primary endpoints were progression-free survival and overall survival. Efficacy analyses were done on the intention-to-treat population, whereas safety was assessed in all patients who received at least one dose of study drug. The results presented in this report reflect the 4-year update of the ongoing study with a database lock date of May 10, 2018. This study is registered with ClinicalTrials.gov, number NCT01844505. Findings Between July 3, 2013, and March 31, 2014, 945 patients were enrolled and randomly assigned to nivolumab plus ipilimumab (n=314), nivolumab (n=316), or ipilimumab (n=315). Median follow-up was 46·9 months (IQR 10·9–51·8) in the nivolumab plus ipilimumab group, 36·0 months (10·5–51·4) in the nivolumab group, and 18·6 months (7·6–49·5) in the ipilimumab group. At a minimum follow-up of 48 months from the date that the final patient was enrolled and randomised, median overall survival was not reached (95% CI 38·2–not reached) in the nivolumab plus ipilimumab group, 36·9 months (28·3–not reached) in the nivolumab group, and 19·9 months (16·9–24·6) in the ipilimumab group. The hazard ratio for death for the combination versus ipilimumab was 0·54 (95% CI 0·44–0·67; p Interpretation The results of this analysis at 4 years of follow-up show that a durable, sustained survival benefit can be achieved with first-line nivolumab plus ipilimumab or nivolumab alone in patients with advanced melanoma. Funding Bristol-Myers Squibb.

Journal ArticleDOI
TL;DR: Nivolumab combined with ipilimumab had clinically meaningful intracranial efficacy, concordant with extracranial activity, in patients with melanoma who had untreated brain metastases.
Abstract: Background Brain metastases are a common cause of disabling neurologic complications and death in patients with metastatic melanoma. Previous studies of nivolumab combined with ipilimumab ...

Journal ArticleDOI
Jeanne E. Savage1, Philip R. Jansen1, Philip R. Jansen2, Sven Stringer1, Kyoko Watanabe1, Julien Bryois3, Christiaan de Leeuw1, Mats Nagel, Swapnil Awasthi4, Peter B. Barr5, Jonathan R. I. Coleman6, Katrina L. Grasby7, Anke R. Hammerschlag1, Jakob Kaminski4, Robert Karlsson3, Eva Krapohl8, Max Lam, Marianne Nygaard9, Chandra A. Reynolds10, Joey W. Trampush11, Hannah Young12, Delilah Zabaneh8, Sara Hägg3, Narelle K. Hansell13, Ida K. Karlsson3, Sten Linnarsson3, Grant W. Montgomery7, Grant W. Montgomery13, Ana B. Muñoz-Manchado3, Erin Burke Quinlan8, Gunter Schumann8, Nathan G. Skene3, Nathan G. Skene14, Bradley T. Webb5, Tonya White2, Dan E. Arking15, Dimitrios Avramopoulos15, Robert M. Bilder16, Panos Bitsios17, Katherine E. Burdick18, Katherine E. Burdick19, Katherine E. Burdick20, Tyrone D. Cannon21, Ornit Chiba-Falek, Andrea Christoforou22, Elizabeth T. Cirulli, Eliza Congdon16, Aiden Corvin23, Gail Davies24, Ian J. Deary24, Pamela DeRosse25, Pamela DeRosse26, Dwight Dickinson27, Srdjan Djurovic28, Srdjan Djurovic29, Gary Donohoe30, Emily Drabant Conley, Johan G. Eriksson31, Thomas Espeseth32, Nelson A. Freimer16, Stella G. Giakoumaki17, Ina Giegling33, Michael Gill23, David C. Glahn21, Ahmad R. Hariri34, Alex Hatzimanolis35, Alex Hatzimanolis36, Matthew C. Keller37, Emma Knowles21, Deborah C. Koltai34, Bettina Konte33, Jari Lahti31, Stephanie Le Hellard28, Todd Lencz26, Todd Lencz25, David C. Liewald24, Edythe D. London16, Astri J. Lundervold28, Anil K. Malhotra26, Anil K. Malhotra25, Ingrid Melle28, Ingrid Melle32, Derek W. Morris30, Anna C. Need38, William Ollier39, Aarno Palotie19, Aarno Palotie31, Aarno Palotie40, Antony Payton39, Neil Pendleton41, Russell A. Poldrack42, Katri Räikkönen31, Ivar Reinvang32, Panos Roussos20, Panos Roussos18, Dan Rujescu33, Fred W. Sabb43, Matthew A. Scult34, Olav B. Smeland32, Nikolaos Smyrnis36, Nikolaos Smyrnis35, John M. Starr24, Vidar M. Steen28, Nikos C. Stefanis35, Nikos C. Stefanis36, Richard E. Straub15, Kjetil Sundet32, Henning Tiemeier2, Aristotle N. Voineskos44, Daniel R. Weinberger15, Elisabeth Widen31, Jin Yu, Gonçalo R. Abecasis45, Ole A. Andreassen32, Gerome Breen6, Lene Christiansen9, Birgit Debrabant9, Danielle M. Dick5, Andreas Heinz4, Jens Hjerling-Leffler3, M. Arfan Ikram46, Kenneth S. Kendler5, Nicholas G. Martin7, Sarah E. Medland7, Nancy L. Pedersen3, Robert Plomin8, Tinca J. C. Polderman1, Stephan Ripke19, Stephan Ripke47, Stephan Ripke4, Sophie van der Sluis, Patrick Sullivan48, Patrick Sullivan3, Scott I. Vrieze12, Margaret J. Wright13, Danielle Posthuma1 
TL;DR: A large-scale genetic association study of intelligence identifies 190 new loci and implicates 939 new genes related to neurogenesis, neuron differentiation and synaptic structure, a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.
Abstract: Intelligence is highly heritable1 and a major determinant of human health and well-being2. Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3-7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer's disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.

Journal ArticleDOI
Andrew Shepherd1, Erik R. Ivins2, Eric Rignot3, Ben Smith4, Michiel R. van den Broeke, Isabella Velicogna3, Pippa L. Whitehouse5, Kate Briggs1, Ian Joughin4, Gerhard Krinner6, Sophie Nowicki7, Tony Payne8, Ted Scambos9, Nicole Schlegel2, Geruo A3, Cécile Agosta, Andreas P. Ahlstrøm10, Greg Babonis11, Valentina R. Barletta12, Alejandro Blazquez, Jennifer Bonin13, Beata Csatho11, Richard I. Cullather7, Denis Felikson14, Xavier Fettweis, René Forsberg12, Hubert Gallée6, Alex S. Gardner2, Lin Gilbert15, Andreas Groh16, Brian Gunter17, Edward Hanna18, Christopher Harig19, Veit Helm20, Alexander Horvath21, Martin Horwath16, Shfaqat Abbas Khan12, Kristian K. Kjeldsen10, Hannes Konrad1, Peter L. Langen22, Benoit S. Lecavalier23, Bryant D. Loomis7, Scott B. Luthcke7, Malcolm McMillan1, Daniele Melini24, Sebastian H. Mernild25, Sebastian H. Mernild26, Sebastian H. Mernild27, Yara Mohajerani3, Philip Moore28, Jeremie Mouginot6, Jeremie Mouginot3, Gorka Moyano, Alan Muir15, Thomas Nagler, Grace A. Nield5, Johan Nilsson2, Brice Noël, Ines Otosaka1, Mark E. Pattle, W. Richard Peltier29, Nadege Pie14, Roelof Rietbroek30, Helmut Rott, Louise Sandberg-Sørensen12, Ingo Sasgen20, Himanshu Save14, Bernd Scheuchl3, Ernst Schrama31, Ludwig Schröder16, Ki-Weon Seo32, Sebastian B. Simonsen12, Thomas Slater1, Giorgio Spada33, T. C. Sutterley3, Matthieu Talpe9, Lev Tarasov23, Willem Jan van de Berg, Wouter van der Wal31, Melchior van Wessem, Bramha Dutt Vishwakarma34, David N. Wiese2, Bert Wouters 
14 Jun 2018-Nature
TL;DR: This work combines satellite observations of its changing volume, flow and gravitational attraction with modelling of its surface mass balance to show that the Antarctic Ice Sheet lost 2,720 ± 1,390 billion tonnes of ice between 1992 and 2017, which corresponds to an increase in mean sea level of 7.6‚¬3.9 millimetres.
Abstract: The Antarctic Ice Sheet is an important indicator of climate change and driver of sea-level rise. Here we combine satellite observations of its changing volume, flow and gravitational attraction with modelling of its surface mass balance to show that it lost 2,720 ± 1,390 billion tonnes of ice between 1992 and 2017, which corresponds to an increase in mean sea level of 7.6 ± 3.9 millimetres (errors are one standard deviation). Over this period, ocean-driven melting has caused rates of ice loss from West Antarctica to increase from 53 ± 29 billion to 159 ± 26 billion tonnes per year; ice-shelf collapse has increased the rate of ice loss from the Antarctic Peninsula from 7 ± 13 billion to 33 ± 16 billion tonnes per year. We find large variations in and among model estimates of surface mass balance and glacial isostatic adjustment for East Antarctica, with its average rate of mass gain over the period 1992–2017 (5 ± 46 billion tonnes per year) being the least certain.

Journal ArticleDOI
31 Aug 2018-Science
TL;DR: The authors' models show that for the three most important grain crops—wheat, rice, and maize—yield lost to insects will increase by 10 to 25% per degree Celsius of warming, hitting hardest in the temperate zone.
Abstract: Insect pests substantially reduce yields of three staple grains—rice, maize, and wheat—but models assessing the agricultural impacts of global warming rarely consider crop losses to insects. We use established relationships between temperature and the population growth and metabolic rates of insects to estimate how and where climate warming will augment losses of rice, maize, and wheat to insects. Global yield losses of these grains are projected to increase by 10 to 25% per degree of global mean surface warming. Crop losses will be most acute in areas where warming increases both population growth and metabolic rates of insects. These conditions are centered primarily in temperate regions, where most grain is produced.

Journal ArticleDOI
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer.
Abstract: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer This portion of the guidelines focuses on the management of localized disease, which involves careful patient selection for curative-intent treatment options that sequence multimodality therapy usually comprised of chemotherapy, radiation, and surgical resection

Journal ArticleDOI
TL;DR: The NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib are summarized.
Abstract: The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.

Journal ArticleDOI
TL;DR: Applying MTAG to summary statistics for depressive symptoms, neuroticism and subjective well-being increased discovery of associated loci as compared to single-trait analyses, yielding more informative bioinformatics analyses and increasing the variance explained by polygenic scores by approximately 25%, matching theoretical expectations.
Abstract: We introduce multi-trait analysis of GWAS (MTAG), a method for joint analysis of summary statistics from genome-wide association studies (GWAS) of different traits, possibly from overlapping samples. We apply MTAG to summary statistics for depressive symptoms (N eff = 354,862), neuroticism (N = 168,105), and subjective well-being (N = 388,538). As compared to the 32, 9, and 13 genome-wide significant loci identified in the single-trait GWAS (most of which are themselves novel), MTAG increases the number of associated loci to 64, 37, and 49, respectively. Moreover, association statistics from MTAG yield more informative bioinformatics analyses and increase the variance explained by polygenic scores by approximately 25%, matching theoretical expectations.

Journal ArticleDOI
25 Apr 2018-Nature
TL;DR: Any application of an optical-frequency source could benefit from the high-precision optical synthesis presented here, and leveraging high-volume semiconductor processing built around advanced materials could allow such low-cost, low-power and compact integrated-photonics devices to be widely used.
Abstract: Optical-frequency synthesizers, which generate frequency-stable light from a single microwave-frequency reference, are revolutionizing ultrafast science and metrology, but their size, power requirement and cost need to be reduced if they are to be more widely used. Integrated-photonics microchips can be used in high-coherence applications, such as data transmission1, highly optimized physical sensors2 and harnessing quantum states3, to lower cost and increase efficiency and portability. Here we describe a method for synthesizing the absolute frequency of a lightwave signal, using integrated photonics to create a phase-coherent microwave-to-optical link. We use a heterogeneously integrated III–V/silicon tunable laser, which is guided by nonlinear frequency combs fabricated on separate silicon chips and pumped by off-chip lasers. The laser frequency output of our optical-frequency synthesizer can be programmed by a microwave clock across 4 terahertz near 1,550 nanometres (the telecommunications C-band) with 1 hertz resolution. Our measurements verify that the output of the synthesizer is exceptionally stable across this region (synthesis error of 7.7 × 10−15 or below). Any application of an optical-frequency source could benefit from the high-precision optical synthesis presented here. Leveraging high-volume semiconductor processing built around advanced materials could allow such low-cost, low-power and compact integrated-photonics devices to be widely used. An optical-frequency synthesizer based on stabilized frequency combs has been developed utilizing chip-scale devices as key components, in a move towards using integrated photonics technology for ultrafast science and metrology.

Journal ArticleDOI
16 Feb 2018-Science
TL;DR: It is shown that human exposure to carbonaceous aerosols of fossil origin is transitioning away from transportation-related sources and toward VCPs, and the focus of efforts to mitigate ozone formation and toxic chemical burdens need to be adjusted.
Abstract: A gap in emission inventories of urban volatile organic compound (VOC) sources, which contribute to regional ozone and aerosol burdens, has increased as transportation emissions in the United States and Europe have declined rapidly. A detailed mass balance demonstrates that the use of volatile chemical products (VCPs)—including pesticides, coatings, printing inks, adhesives, cleaning agents, and personal care products—now constitutes half of fossil fuel VOC emissions in industrialized cities. The high fraction of VCP emissions is consistent with observed urban outdoor and indoor air measurements. We show that human exposure to carbonaceous aerosols of fossil origin is transitioning away from transportation-related sources and toward VCPs. Existing U.S. regulations on VCPs emphasize mitigating ozone and air toxics, but they currently exempt many chemicals that lead to secondary organic aerosols.

Journal ArticleDOI
18 Apr 2018-Nature
TL;DR: A way of integrating photonics with silicon nanoelectronics is described, using polycrystalline silicon on glass islands alongside transistors on bulk silicon complementary metal–oxide–semiconductor chips to address the demand for high-bandwidth optical interconnects in data centres and high-performance computing.
Abstract: Electronic and photonic technologies have transformed our lives-from computing and mobile devices, to information technology and the internet. Our future demands in these fields require innovation in each technology separately, but also depend on our ability to harness their complementary physics through integrated solutions1,2. This goal is hindered by the fact that most silicon nanotechnologies-which enable our processors, computer memory, communications chips and image sensors-rely on bulk silicon substrates, a cost-effective solution with an abundant supply chain, but with substantial limitations for the integration of photonic functions. Here we introduce photonics into bulk silicon complementary metal-oxide-semiconductor (CMOS) chips using a layer of polycrystalline silicon deposited on silicon oxide (glass) islands fabricated alongside transistors. We use this single deposited layer to realize optical waveguides and resonators, high-speed optical modulators and sensitive avalanche photodetectors. We integrated this photonic platform with a 65-nanometre-transistor bulk CMOS process technology inside a 300-millimetre-diameter-wafer microelectronics foundry. We then implemented integrated high-speed optical transceivers in this platform that operate at ten gigabits per second, composed of millions of transistors, and arrayed on a single optical bus for wavelength division multiplexing, to address the demand for high-bandwidth optical interconnects in data centres and high-performance computing3,4. By decoupling the formation of photonic devices from that of transistors, this integration approach can achieve many of the goals of multi-chip solutions 5 , but with the performance, complexity and scalability of 'systems on a chip'1,6-8. As transistors smaller than ten nanometres across become commercially available 9 , and as new nanotechnologies emerge10,11, this approach could provide a way to integrate photonics with state-of-the-art nanoelectronics.

Journal ArticleDOI
05 Jan 2018-Science
TL;DR: A class of soft actuators is described, termed hydraulically amplified self-healing electrostatic (HASEL) actuators, which harness a mechanism that couples electrostatic and hydraulic forces to achieve a variety of actuation modes and demonstrate their robust, muscle-like performance as well as their ability to repeatedly self- heal after dielectric breakdown.
Abstract: Existing soft actuators have persistent challenges that restrain the potential of soft robotics, highlighting a need for soft transducers that are powerful, high-speed, efficient, and robust. We describe a class of soft actuators, termed hydraulically amplified self-healing electrostatic (HASEL) actuators, which harness a mechanism that couples electrostatic and hydraulic forces to achieve a variety of actuation modes. We introduce prototypical designs of HASEL actuators and demonstrate their robust, muscle-like performance as well as their ability to repeatedly self-heal after dielectric breakdown—all using widely available materials and common fabrication techniques. A soft gripper handling delicate objects and a self-sensing artificial muscle powering a robotic arm illustrate the wide potential of HASEL actuators for next-generation soft robotic devices.

Journal ArticleDOI
26 Jul 2018-Nature
TL;DR: A synopsis of the current understanding of the spatio-temporal complexity of this important climate mode and its influence on the Earth system is provided and a unifying framework that identifies the key factors for this complexity is proposed.
Abstract: El Nino events are characterized by surface warming of the tropical Pacific Ocean and weakening of equatorial trade winds that occur every few years Such conditions are accompanied by changes in atmospheric and oceanic circulation, affecting global climate, marine and terrestrial ecosystems, fisheries and human activities The alternation of warm El Nino and cold La Nina conditions, referred to as the El Nino–Southern Oscillation (ENSO), represents the strongest year-to-year fluctuation of the global climate system Here we provide a synopsis of our current understanding of the spatio-temporal complexity of this important climate mode and its influence on the Earth system

Journal ArticleDOI
13 Jul 2018-Science
TL;DR: The magnitude of this leakage was reassessed and it was found that in 2015, supply chain emissions were ∼60% higher than the U.S. Environmental Protection Agency inventory estimate, likely because existing inventory methods miss emissions released during abnormal operating conditions.
Abstract: Methane emissions from the U.S. oil and natural gas supply chain were estimated by using ground-based, facility-scale measurements and validated with aircraft observations in areas accounting for ~30% of U.S. gas production. When scaled up nationally, our facility-based estimate of 2015 supply chain emissions is 13 ± 2 teragrams per year, equivalent to 2.3% of gross U.S. gas production. This value is ~60% higher than the U.S. Environmental Protection Agency inventory estimate, likely because existing inventory methods miss emissions released during abnormal operating conditions. Methane emissions of this magnitude, per unit of natural gas consumed, produce radiative forcing over a 20-year time horizon comparable to the CO2 from natural gas combustion. Substantial emission reductions are feasible through rapid detection of the root causes of high emissions and deployment of less failure-prone systems.

Journal ArticleDOI
TL;DR: The Lancet Countdown tracks 41 indicators across five domains: climate change impacts, exposures, and vulnerability; adaptation, planning, and resilience for health; mitigation actions and health co-benefits; finance and economics; and public and political engagement.